Tenofovir Versus Lamivudine for Patients of Chronic Hepatitis B With Severe Acute Exacerbation (HBSAE)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01848743|
Recruitment Status : Unknown
Verified September 2014 by Wei-Lun Tsai, Kaohsiung Veterans General Hospital..
Recruitment status was: Recruiting
First Posted : May 7, 2013
Last Update Posted : September 16, 2014
Kaohsiung Veterans General Hospital.
Information provided by (Responsible Party):
Wei-Lun Tsai, Kaohsiung Veterans General Hospital.
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||April 2016|
|Estimated Study Completion Date :||October 2016|